BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2515615)

  • 1. The effect of venous occlusion on the PAI and antiplasmins release from platelets.
    Woods AI; Nadra CA; Lazzari MA
    Thromb Res; 1989 Nov; 56(3):491-5. PubMed ID: 2515615
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen activation system of the platelets.
    Park S
    Rinsho Byori; 1992 Mar; Suppl 92():131-43. PubMed ID: 1583771
    [No Abstract]   [Full Text] [Related]  

  • 3. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.
    Sørensen JV
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
    Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
    J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulatory mechanisms of PAI-1 on fibrinolysis in vascular endothelial cells].
    Sakata Y
    Rinsho Byori; 1989 Apr; Spec No 81():149-55. PubMed ID: 2502640
    [No Abstract]   [Full Text] [Related]  

  • 7. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA; Booth NA; Croll AM; Bennett B
    Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
    Voss R; Matthias FR; Borkowski G; Reitz D
    Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
    J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of fibrinolysis during labour with and without aprotinin application].
    Kühnert M; Stein W; Tekesin I; Hellmeyer L; Schmidt S
    Z Geburtshilfe Neonatol; 2003; 207(3):90-100. PubMed ID: 12891467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator release and plasminogen activator inhibitor levels in coronary artery disease.
    Meyers DG; Haire WD; Rasmussen JK; Boyd EJ
    Angiology; 1991 Jul; 42(7):561-7. PubMed ID: 1907440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers.
    Ozdemir O; Karaaslan Y; Ozcebe O; Dündar S; Kirazli S
    Thromb Res; 1992 Jan; 65(2):263-74. PubMed ID: 1533735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin effect on platelet antiplasmins release.
    Woods AI; Lazzari MA
    Thromb Res; 1987 Aug; 47(3):269-77. PubMed ID: 3629554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.
    Brandtzaeg P; Joø GB; Brusletto B; Kierulf P
    Thromb Res; 1990 Jan; 57(2):271-8. PubMed ID: 2315889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibrinolysis during and after normal childbirth.
    Mackinnon S; Walker ID; Davidson JF; Walker JJ
    Br J Haematol; 1987 Mar; 65(3):339-42. PubMed ID: 2436648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells.
    Diamond SL; Eskin SG; McIntire LV
    Science; 1989 Mar; 243(4897):1483-5. PubMed ID: 2467379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of plasminogen activator inhibitor (PAI) activity of human plasma after dilution in a PAI-depleted plasma.
    Contant G; Martinoli JL
    Thromb Res; 1989 Nov; 56(3):377-86. PubMed ID: 2515610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of hemostasis in ischemic cerebrovascular disease. III. Abnormalities in vascular plasminogen activators, antiactivators and alpha 2-antiplasmin.
    Mettinger KL; Egberg N
    Thromb Res; 1982 May; 26(3):203-10. PubMed ID: 6810498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.